跳转至内容
Merck
所有图片(1)

主要文件

328007

Sigma-Aldrich

ERK抑制剂II,FR180204

ERK Inhibitor II, FR 180204, CAS 865362-74-9, is a cell-permeable, potent, ATP-competitive inhibitor of ERK1 and ERK2 (IC₅₀ = 510 nM and 330 nM; Ki = 310 nM and 140 nM, respectively).

别名:

ERK抑制剂II,FR180204, 5-(2-苯基-吡唑并[1,5-a]吡啶-3-基)-1H-吡唑并[3,4-c]哒嗪-3-基胺

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C18H13N7
分子量:
327.34
MDL號碼:
分類程式碼代碼:
12352200

品質等級

化驗

≥98% (HPLC)

形狀

solid

製造商/商標名

Calbiochem®

儲存條件

OK to freeze
protect from light

顏色

yellow

溶解度

DMSO: 10 mg/mL

運輸包裝

ambient

儲存溫度

2-8°C

InChI

1S/C18H13N7/c19-17-12-10-13(20-22-18(12)23-21-17)15-14-8-4-5-9-25(14)24-16(15)11-6-2-1-3-7-11/h1-10H,(H3,19,21,22,23)

InChI 密鑰

XVECMUKVOMUNLE-UHFFFAOYSA-N

一般說明

一种细胞可渗透性吡唑并哒嗪,可作为ERK1和ERK2的有效,ATP竞争性抑制剂(IC50分别为510 nM和330 nM;Ki分别为310 nM和140 nM)。选择性比p38高约20倍α(IC50 = 10 µM),对IKKα、MEK1、MKK4、PDGFRα、PKCα、Src和Syk几乎没有活性,即使在浓度高达30 µM时也是如此。在Mv1Lu上皮细胞中显示出抑制TGFβ−-诱导的AP-1活化的作用(IC50为3.1 µM)。也可用ERK抑制剂II,阴性对照(目录编号328008)。 也可以10 mM的DMSO溶液(目录号328010)提供。
一种细胞可渗透性吡唑并哒嗪,可作为ERK1和ERK2的有效,ATP竞争性抑制剂(IC50分别为510 nM和330 nM;Ki分别为310 nM和140 nM)。选择性比p38高约20倍α(IC50 = 10 µM),对IKKα、MEK1、MKK4、PDGFRα、PKCα、Src和Syk几乎没有活性,即使在浓度高达30 µM时也是如此。在Mv1Lu上皮细胞中显示出抑制TGFβ−-诱导的AP-1活化的作用(IC50为3.1 µM)。也可用ERK抑制剂II,阴性对照(目录编号328008)。也可提供InSolution形式(目录号328010)。

生化/生理作用

主要靶标
ERK1和ERK2
产物与ATP竞争。
可逆:否
细胞可渗透性:是
靶标IC50:510 nm和330 nm
靶标Ki:310 nM和140 nM,分别针对ERK1和ERK2

包裝

用惰性气体包装

警告

毒性:标准处理(A)

重構

复溶后,等分并冷冻保存(-20°C)。储备溶液在-20°C下可稳定保存至多6个月。

其他說明

Ohori, M., et al. 2005.Biochem.Biophys.Res. Commun.336, 357.

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Jiawen Yong et al.
International journal of molecular sciences, 23(15) (2022-08-13)
Ciliary neurotrophic factor (CNTF) was identified as a survival factor in various types of peripheral and central neurons, glia and non-neural cells. At present, there is no available data on the expression and localization of CNTF-receptors in cementoblasts as well
Jiawen Yong et al.
Journal of cellular and molecular medicine, 25(20), 9710-9723 (2021-09-16)
Hypoxia-induced apoptosis of cementoblasts (OCCM-30) may be harmful to orthodontic treatment. Hypoxia-inducible factor 1-alpha (HIF-1α) mediates the biological effects during hypoxia. Little is known about the survival mechanism capable to counteract cementoblast apoptosis. We aimed to investigate the potential roles
G Ruiz-Heiland et al.
Clinical oral investigations, 25(4), 1933-1944 (2020-08-21)
Juvenile obesity is a complex clinical condition that is present more and more frequently in the daily orthodontic practice. Over-weighted patients have an impaired bone metabolism, due in part to their increased levels of circulating adipokines. Particularly, leptin has been
Yen-You Lin et al.
Journal of cellular physiology, 236(10), 6988-7000 (2021-03-28)
The pro-inflammatory cytokine interleukin 1 beta (IL-1β) plays a critical role in osteoarthritis (OA) disease pathogenesis. MicroRNA (miRNA) activity is related to inflammation in OA and some miRNAs specifically regulate IL-mediated degradation of cartilage type II collagen. Previous studies have
Zahra S Thirouin et al.
The Journal of biological chemistry, 298(5), 101840-101840 (2022-03-22)
Posttranslational addition of a small ubiquitin-like modifier (SUMO) moiety (SUMOylation) has been implicated in pathologies such as brain ischemia, diabetic peripheral neuropathy, and neurodegeneration. However, nuclear enrichment of SUMO pathway proteins has made it difficult to ascertain how ion channels

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门